Publizoom

Award notice Supplies

Acuerdo marco de suministro de medicamentos oncológicos

Notice published in Spanish. The AI analysis summarises it for you in your language.

Public buyer
Consorci de Salut i d'Atenció Social de Catalunya
No consta
Place of performance
No consta
Amount awarded
€24,435,784 excl. VAT
Bids received
7
Form
Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure
Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication
15 July 2026
Notice language
Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Acuerdo Marco del Suministro de Medicamentos ONCOLÓGICOS

Awarded to

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33690000

Winning prices for comparable contracts

A quarter below
€202,502
Median
€425,325
A quarter above
€1,046,198

Amounts awarded (excl. VAT) over the last 3 years for 163 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

ContractWinnerAmount
Acuerdo Marco del Suministro de los Medicamentos AXITINIB Y PAZOPANIB
Consorci de Salut i d'Atenció Social de Catalunya · 8 September 2026
TEVA PHARMA
REDDY PHARMA IBÉRIA, S.A.
ACCORD HEALTHCARE, S.L.U.
LABORATORIO STADA, S.L.
GLENMARK FARMACÉUTICA, S.L.U.
€3,219,873
Acuerdo marco del suministro de somatropina para el síndrome de noonan
Consorci de Salut i d'Atenció Social de Catalunya · 13 July 2026
NOVO NORDISK PHARMA, S.A. €1,097,250
Adjudicación del Contrato Específico del Medicamento FUMARATO DE DIROXIMEL, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para la Corporació de Salut del Maresme i la Selva
Corporació de Salut del Maresme i la Selva · 23 October 2026
BIOGEN SPAIN S.L. €332,714
23/S/25/SU/DG/A/AM33 - Medicamentos no exclus. de uso humano Tipo I - Incluidos en el grupo terapéutico M Y N
Dirección General de Recursos Económicos del Servicio Canario de la Salud · 23 October 2026
LABORATORIOS NORMON, S.A.
TEVA PHARMA SLU
TARBIS FARMA S.L.
SUN PHARMA LABORATORIOS, SLU
€463,493
Adjudicación del Contrato Basado del Acuerdo Marco del Suministro de MEDICAMENTOS ANTIRRETROVIRALES del Consorci Sanitari Integral
Consorci Sanitari Integral · 23 October 2026
EMPRESAS ADJUDICADAS EN EL CONTRATO BASADO (homologadas en el acuerdo marco de referencia) €17,802,819

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 489394-2026.